Suchergebnisse - "Armuzzi, Alessandro"

PubPharm (31)

1

Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn's Disease in Italy

enthalten in: Advances in therapy | 2024

von Dovizio, M. | Hartz, S. | Buzzoni, C. | +7

2

Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials

enthalten in: BMC gastroenterology | 2024

von Peyrin-Biroulet, L. | Arkkila, P. | Armuzzi, A. | +14

3

Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials

enthalten in: BMC gastroenterology | 2024

von Peyrin‐Biroulet, L. | Arkkila, P. | Armuzzi, A. | +13

4

Timing of proper introduction, optimization and maintenance of anti-TNF therapy in IBD : Results from a Delphi consensus

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2024

von Ardizzone, S. | Armuzzi, A. | Caprioli, F. | +8

5

Nutritional care at centres managing patients with inflammatory bowel disease : A nationwide survey in Italy

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2023

von Saibeni, S. | Zanetti, M. | Bezzio, C. | +10

CommentIn: Dig Liver Dis. 2023 Aug;55(8):1026-1027. - PMID 37355396

6

SARS-CoV-2 infection in patients with inflammatory bowel disease : comparison between the first and second pandemic waves

enthalten in: BMC gastroenterology | 2023

von Bezzio, C. | Vernero, M. | Costa, S. | +72

7

SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves

enthalten in: BMC gastroenterology | 2023

von Bezzio, C. | Vernero, M. | Costa, S. | +31

8

SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves

enthalten in: BMC gastroenterology | 2023

von Bezzio, C. | Vernero, M. | Costa, S. | +31

9

Artificial intelligence and inflammatory bowel disease : Where are we going?

enthalten in: World journal of gastroenterology | 2023

von Da Rio, L. | Spadaccini, M. | Parigi, T. | +13

10

Improvements in Disease Activity Partially Mediate the Effect of Tofacitinib Treatment on Generic and Disease-Specific Health-Related Quality of Life in Patients with Ulcerative Colitis : Data from the OCTAVE Program

enthalten in: Digestive diseases (Basel, Switzerland) | 2023

von Dubinsky, M. | Armuzzi, A. | Gecse, K. | +7